Nkarta, Inc. (NASDAQ:NKTX) Stock Has Average Target Price of $11.20

Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $11.20.

NKTX has been the topic of a number of analyst reports. HC Wainwright initiated coverage on shares of Nkarta in a report on Monday, November 2nd. They issued a “buy” rating on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Nkarta in a research note on Monday, September 21st. Needham & Company LLC reissued a “buy” rating on shares of Nkarta in a research note on Monday, November 9th. Wall Street Zen cut shares of Nkarta from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 15th. Finally, Stifel Nicolaus dropped their price target on shares of Nkarta from $11.00 to $10.00 and set a “buy” rating on the stock in a research note on Friday, August 14th.

View Our Latest Stock Analysis on NKTX

Hedge Funds Weigh In On Nkarta

Several hedge funds and other institutional investors have recently made changes to their positions in NKTX. Empowered Funds LLC increased its position in Nkarta by 55.3% in the 3rd quarter. Empowered Funds LLC now owns 108,165 shares of the company’s stock valued at $283,000 after acquiring an additional 38,523 shares during the period. StoneX Group Inc. bought a new stake in Nkarta during the 3rd quarter valued at $53,000. Samalin Investment Counsel LLC boosted its position in Nkarta by 68.5% during the 3rd quarter. Samalin Investment Counsel LLC now owns 68,658 shares of the company’s stock worth $180,000 after acquiring an additional 27,908 shares during the period. WINTON GROUP Ltd acquired a new position in Nkarta during the 2nd quarter worth $45,000. Finally, Spark Investment Management LLC acquired a new position in Nkarta during the 2nd quarter worth $33,000. 80.54% of the stock is currently owned by institutional investors and hedge funds.

Nkarta Price Performance

Shares of NASDAQ NKTX opened at $1.12 on Tuesday. Nkarta has a 1-year low of $1.10 and a 1-year high of $3.72. The business’s fifty day moving average price is $2.06 and its two-hundred day moving average price is $2.47. The firm has a market capitalization of $80.30 million, a PE ratio of -0.65 and a beta of 1.24.

Nkarta (NASDAQ:NKTX – Get Free Report) last posted its earnings results on Tuesday, November 10th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.05). Equities research analysts expect that Nkarta will post -1.67 earnings per share for the current fiscal year.

About Nkarta

(Get Free Report)

Nkarta, Inc. is a clinical-stage biotechnology company developing cell therapies based on natural killer (NK) cells, immune cells that can identify and attack abnormal cells. The company’s approach uses donor-derived NK cells that are engineered to recognize cancer targets and intended for use as off-the-shelf treatments. Nkarta’s research programs have included NKX019, an engineered NK-cell therapy targeting CD19, a protein found on certain B-cell cancers, and NKX101, designed to recognize stress signals on cancer cells.

Featured Stories

Analyst Recommendations for Nkarta (NASDAQ:NKTX)

Receive News & Ratings for Nkarta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nkarta and related companies with MarketBeat.com's FREE daily email newsletter.